Iotalamic acid

Iotalamic acid is an organoiodine compound extensively used as a contrast medium in various medical imaging modalities. With its unique physicochemical properties, iotalamic acid significantly enhances the contrast in imaging studies, aiding in accurate diagnosis and evaluation.

Chemical and Physical Properties[edit | edit source]

Iotalamic acid belongs to the family of iodinated contrast media, characterized by their ability to absorb X-rays. The presence of iodine atoms in these molecules is the primary reason for their utility in radiographic imaging. When administered, they can delineate structures or fluids within the body, enabling clear visualization under X-ray examination^[1].

Clinical Applications[edit | edit source]

Iotalamic acid is indicated for a variety of radiological studies such as:

As a contrast agent, it functions to highlight specific areas or structures within the body, thus optimizing the clarity of imaging and enabling precise interpretation^[2].

Pharmacokinetics[edit | edit source]

Following its intravascular injection, iotalamic acid distributes in the extracellular fluid space. Its elimination predominantly occurs via renal excretion, and thus its clearance is directly related to the renal function of the patient^[3].

Safety and Adverse Effects[edit | edit source]

Like other contrast agents, iotalamic acid has the potential to induce adverse reactions. While most of these reactions are mild and self-limiting, severe reactions, although rare, can occur. It is critical for healthcare providers to be aware of these potential reactions and to monitor patients closely during and after its administration.

Common side effects include:

Warm sensation
Nausea
Vomiting
Urticaria

Severe reactions can range from respiratory distress, hypotension, and in rare instances, anaphylaxis^[4].

Conclusion[edit | edit source]

Iotalamic acid has served as a pivotal contrast agent in radiological practices, providing enhanced visualization in various imaging modalities. It is essential for practitioners to be knowledgeable about its properties, indications, and potential risks to ensure its effective and safe administration.

References[edit | edit source]

Katzberg, R. W., & Newhouse, J. H. (2010). Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology, 256(1), 21-28.
Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. British Journal of Radiology, 76(908), 513-518.
Bush, W. H., & Swanson, D. P. (1991). Contrast media reactions and extravasation: relationship to intravenous contrast media administration techniques. Radiographics, 11(4), 581-590.
ACR Committee on Drugs and Contrast Media. (2018). ACR manual on contrast media. American College of Radiology.

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

↑ Katzberg, R. W., & Newhouse, J. H. (2010). Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology, 256(1), 21-28.
↑ Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. British Journal of Radiology, 76(908), 513-518.
↑ Bush, W. H., & Swanson, D. P. (1991). Contrast media reactions and extravasation: relationship to intravenous contrast media administration techniques. Radiographics, 11(4), 581-590.
↑ ACR Committee on Drugs and Contrast Media. (2018). ACR manual on contrast media. American College of Radiology.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

[1] Katzberg, R. W., & Newhouse, J. H. (2010). Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology, 256(1), 21-28.

[2] Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. British Journal of Radiology, 76(908), 513-518.

[3] Bush, W. H., & Swanson, D. P. (1991). Contrast media reactions and extravasation: relationship to intravenous contrast media administration techniques. Radiographics, 11(4), 581-590.

[4] ACR Committee on Drugs and Contrast Media. (2018). ACR manual on contrast media. American College of Radiology.

[1]

[2]

[3]

[4]